SCHEMBL8430872

SCHEMBL8430872

N[C@@H](CCS)C(=O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Homocysteine SCHEMBL936365 0.78 PTGS1 (0.62) —
L-Homocysteine SCHEMBL35837 0.78 — —
Homocysteine SCHEMBL28927454 0.78 PTGS1 (0.62) —
Homocysteine SCHEMBL35836 0.78 — —
L-Homocysteine SCHEMBL936366 0.78 PTGS1 (0.62) —
SCHEMBL7196813 0.78 — —
SCHEMBL4632678 0.78 — —
Homocysteine SCHEMBL601148 0.78 — —
SCHEMBL16033448 0.77 — —
SCHEMBL58409 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4663239-A2 PEGYLATED CYSTATHIONINE BETA SYNTHASE FOR ENZYME THERAPY FOR TREATMENT OF HOMOCYSTINURIA Travere Therapeutics Switzerland GmbH (CH) 2025-12-17 — — EP disclosed
EP-3990005-B1 PEGYLATED CYSTATHIONINE BETA SYNTHASE FOR ENZYME THERAPY FOR TREATMENT OF HOMOCYSTINURIA TRAVERE THERAPEUTICS SWITZERLAND GMBH (CH) 2025-08-27 — — EP disclosed
US-12364765-B2 Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2025-07-22 — — US disclosed
US-20240417428-A1 POLYPEPTIDE FOR INHIBITING TRPM8 AND USE THEREOF ZHEJIANG UNIVERSITY (CN) 2024-12-19 — — US disclosed
CN-116840197-A 2' -O-methyltransferase activity detection method, kit and application 中国科学院苏州生物医学工程技术研究所 2023-10-03 — — CN disclosed
CN-116448842-A Homocysteine electrochemical sensor and preparation method and application thereof 中南民族大学 2023-07-18 — — CN disclosed
US-20230220443-A1 CHARACTERIZATION OF S-ADENOSYL-L-METHIONINE-CONSUMING ENZYMES WITH 1-STEP EZ-MTASE: A UNIVERSAL COUPLED-ASSAY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-07-13 — — US disclosed
EP-4188917-A1 PREPARATION OF ERDOSTEINE OR A DERIVATIVE THEREOF USING A CONTINUOUS FLOW PROCESS EDMOND PHARMA S.R.L. (IT) 2023-06-07 — — EP disclosed
US-20220290116-A1 CYSTATHIONINE BETA-SYNTHASE ENZYME THERAPY FOR TREATMENT OF ELEVATED HOMOCYSTEINE LEVELS TRAVERE THERAPEUTICS SWITZERLAND GMBH (CH) 2022-09-15 — — US disclosed
US-20220265835-A1 PEGYLATED CYSTATHIONINE BETA SYNTHASE FOR ENZYME THERAPY FOR TREATMENT OF HOMOCYSTINURIA ORPHAN TECHNOLOGIES, LTD. (CH) 2022-08-25 — — US disclosed
CN-114786712-A PEGylated cystathionine beta synthetase for use in enzyme therapy for the treatment of homocystinuria 特拉维尔治疗瑞士有限公司 2022-07-22 — — CN disclosed
CN-114630673-A Cystathionine beta-synthase enzyme therapy for treating elevated homocysteine levels 特拉维尔治疗瑞士有限公司 2022-06-14 — — CN disclosed
EP-3990005-A1 PEGYLATED CYSTATHIONINE BETA SYNTHASE FOR ENZYME THERAPY FOR TREATMENT OF HOMOCYSTINURIA Travere Therapeutics Switzerland GmbH (CH) 2022-05-04 — — EP disclosed
WO-2022023929-A1 PREPARATION OF ERDOSTEINE OR A DERIVATIVE THEREOF USING A CONTINUOUS FLOW PROCESS EDMOND PHARMA S.R.L. (IT) 2022-02-03 — — WO disclosed
CN-104558119-B YAP albumen inhibits polypeptide and its application 上海宝恒泓康生物技术有限公司 2019-03-08 — — CN disclosed
CN-100404688-C High specificity homocysteine assays for biological samples ANTICANCER INC (US) 2008-07-23 — — CN disclosed
CN-1268978-A High specificity homocysteine assays for biological samples ANTICANCER INC (US) 2000-10-04 — — CN disclosed
US-6007792-A CHELATE COMPOUNDS LABELED WITH TECHNETIUM-99M, RHENIUM-186, OR RHENIUM-188; TUMOR IMAGING DIATIDE, INC. (US) 1999-12-28 — — US disclosed
EP-0820313-A2 RADIOLABELED PEPTIDES FOR DIAGNOSIS AND THERAPY Diatide, Inc. (US) 1998-01-28 — — EP disclosed
WO-1996030055-A2 RADIOLABELED PEPTIDES FOR DIAGNOSIS AND THERAPY DIATIDE, INC. (US) 1996-10-03 — — WO disclosed
Send feedback